LABORATORY FOR IMMUNOMODULATORY BIOMATERIALS
MERGING NANOTECHNOLOGY AND IMMUNE ENGINEERING TO CREATE NOVEL PHARMACEUTICALS
We are currently recruiting 1 postdoc to work on an NIH funded project. We are not recruiting Ph.D. students for Fall 2022.
Our objective is to build a multidisciplinary team of scientists from fields including systems biology, immunology, biomedical engineering, polymer chemistry, and biomaterials, to create world-changing treatments and devices.
The Pearson Lab is focused on developing strategies for treating dysregulated immune responses such as allergy, inflammation, and cancer through the intersection of two enabling disciplines, nanotechnology and immune engineering.
1. Lasola, J.J.M. et al. Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK. Pharmaceutics 2021. In press
2. Truong, N., et al. Microfluidics-generated immunomodulatory nanoparticles and formulation-dependent effects on lipopolysaccharide-induced macrophage inflammation. The AAPS Journal 2021. In press.
Ryan M. Pearson, Ph.D.
Department of Pharmaceutical Sciences
University of Maryland School of Pharmacy
20 N. Pine Street, N525
Baltimore, MD 21201